Profile: Emergent BioSolutions Inc. is a biopharmaceutical company that focuses on the development & manufacturing of vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Our Biothrax® is a vaccine for the prevention of anthrax. Our spi-VEC delivery platform is based on two independently attenuating and non-reverting deletions engineered into the S. typhi chromosome, one of which is designed to prevent systemic spread of the vaccine strain, an important safety consideration for live vaccines. Our MVAtor™ is a tool for gene expression and vaccine development.